Solarea Bio is a biotechnology company that develops microbial-based solutions for human health and nutrition.

Solarea Bio

Solarea Bio is a clinical-stage biotechnology company in Cambridge, MA developing plant-based microbial solutions to some of the world’s largest health problems.  Solarea was founded in 2017 by a group of scientists and entrepreneurs eager to radically alter our understanding of the human microbiome and utilize its power to improve human health. The Solarea breakthrough came from the combined efforts of the company’s co-founders who established a link between the discovery of an untapped source of microorganisms with probiotic potential in healthy foods, and their applications in inflammatory processes including the gut-musculoskeletal axis. Using powerful genomic and bioinformatic tools, Solarea is mining its novel microbial strain collection to identify synergistic combinations of microbes and prebiotic plant fibers to develop solutions for patients suffering from inflammatory processes.

National Institute on Aging

Rising Tide

Social Starts

Viking Global Investors

Bold Capital Partners

GISEV Family Office

S2G Ventures

GG 1978

We are pleased to announce the hiring of Ilissa Larimore as our  Chief Commercial Officer. As a seasoned commercial executive, Ilissa will oversee all commercial activities, driving the strategy for sales, marketing, practitioner partnerships and industry collaborations at Solarea. She will focus on advancing new products to market utilizing Solarea's innovative technology platform, with a particular focus on medical foods.

We are so excited to have you join us, Ilissa. Welcome to the team!!

https://lnkd.in/eKqQjcua

Today we announce the Beta-launch of our first Medical Food product, Bondia, for the dietary management of postmenopausal bone health. Bondia is currently undergoing a large clinical trial in early postmenopausal women, with expected readouts later this summer. The Bondia Medical Food will be commericalized under Solarea's newly unveiled consumer brand, Journa. This is a huge milestone for the Solarea team as we gear up for an anticipated full product launch in September 2024. Stay tuned for more!

https://lnkd.in/dU9qHASp

Metric
Company Name	Solarea Bio
Symbol
MSH ID	COM:SOLAREABIO
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage
Employee Count	20
Website	solareabio.com
LinkedIn	solareabioinc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	100
Web Traffic Growth	-0.90
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SOLA

COM:SOLAREABIO

Solarea Bio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue